메뉴 건너뛰기




Volumn 20, Issue 9, 2014, Pages 2326-2337

PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN S6; TUMOR MARKER;

EID: 84899752893     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-2267     Document Type: Article
Times cited : (41)

References (49)
  • 2
    • 79952202663 scopus 로고    scopus 로고
    • Molecular markers for the diagnosis and management of ductal carcinoma in situ
    • Polyak K. Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010:210-3.
    • (2010) J Natl Cancer Inst Monogr , vol.2010 , pp. 210-213
    • Polyak, K.1
  • 3
    • 84884286419 scopus 로고    scopus 로고
    • Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
    • Cowell CF, Weigelt B, Sakr RA, Ng CK, Hicks J, King TA, et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol 2013;7:859-69.
    • (2013) Mol Oncol , vol.7 , pp. 859-869
    • Cowell, C.F.1    Weigelt, B.2    Sakr, R.A.3    Ng, C.K.4    Hicks, J.5    King, T.A.6
  • 4
    • 0003964361 scopus 로고    scopus 로고
    • American Cancer Society. Atlanta, GA: American Cancer Society
    • American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society; 2013.
    • (2013) Cancer Facts and Figures 2013
  • 5
    • 0015873713 scopus 로고
    • On the origin and progression of ductal carcinoma in the human breast
    • Wellings SR, Jensen HM. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst 1973;50:1111-8.
    • (1973) J Natl Cancer Inst , vol.50 , pp. 1111-1118
    • Wellings, S.R.1    Jensen, H.M.2
  • 6
    • 0032980789 scopus 로고    scopus 로고
    • Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways
    • Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999;187: 396-402.
    • (1999) J Pathol , vol.187 , pp. 396-402
    • Buerger, H.1    Otterbach, F.2    Simon, R.3    Poremba, C.4    Diallo, R.5    Decker, T.6
  • 7
    • 0032694072 scopus 로고    scopus 로고
    • Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
    • Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999;189:521-6.
    • (1999) J Pathol , vol.189 , pp. 521-526
    • Buerger, H.1    Otterbach, F.2    Simon, R.3    Schafer, K.L.4    Poremba, C.5    Diallo, R.6
  • 10
    • 84877950429 scopus 로고    scopus 로고
    • A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast
    • Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 2013;105: 701-10.
    • (2013) J Natl Cancer Inst , vol.105 , pp. 701-710
    • Solin, L.J.1    Gray, R.2    Baehner, F.L.3    Butler, S.M.4    Hughes, L.L.5    Yoshizawa, C.6
  • 12
    • 58549085378 scopus 로고    scopus 로고
    • Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization
    • Gao Y, Niu Y, Wang X, Wei L, Lu S. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization. J Mol Med 2009;87:145-52.
    • (2009) J Mol Med , vol.87 , pp. 145-152
    • Gao, Y.1    Niu, Y.2    Wang, X.3    Wei, L.4    Lu, S.5
  • 13
    • 84867232961 scopus 로고    scopus 로고
    • Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast
    • Liao S, Desouki MM, Gaile DP, Shepherd L, Nowak NJ, Conroy J, et al. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast. Genes Chromosomes Cancer 2012;51: 1067-78.
    • (2012) Genes Chromosomes Cancer , vol.51 , pp. 1067-1078
    • Liao, S.1    Desouki, M.M.2    Gaile, D.P.3    Shepherd, L.4    Nowak, N.J.5    Conroy, J.6
  • 14
    • 33646253192 scopus 로고    scopus 로고
    • Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression
    • Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006;66:4065-78.
    • (2006) Cancer Res , vol.66 , pp. 4065-4078
    • Yao, J.1    Weremowicz, S.2    Feng, B.3    Gentleman, R.C.4    Marks, J.R.5    Gelman, R.6
  • 15
    • 84865790047 scopus 로고    scopus 로고
    • An integrated encyclopedia of DNA elements in the human genome
    • ENCODE Project Consortium
    • ENCODE Project Consortium, DunhamI, Kundaje A, Aldred SF, Collins PJ, Davis CA, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
    • (2012) Nature , vol.489 , pp. 57-74
    • Dunham, I.1    Kundaje, A.2    Aldred, S.F.3    Collins, P.J.4    Davis, C.A.5
  • 16
    • 79959769583 scopus 로고    scopus 로고
    • Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: A multiplex ligation-dependent probe amplification study
    • Moelans CB, de Wegers RA, Monsuurs HN, Maess AH, van Diest PJ. Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Cell Oncol 2011;34:475-82.
    • (2011) Cell Oncol , vol.34 , pp. 475-482
    • Moelans, C.B.1    De Wegers, R.A.2    Monsuurs, H.N.3    Maess, A.H.4    Van Diest, P.J.5
  • 18
    • 84863716153 scopus 로고    scopus 로고
    • Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
    • Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, et al. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Breast Cancer Res Treat 2012;133:889-98.
    • (2012) Breast Cancer Res Treat , vol.133 , pp. 889-898
    • Johnson, C.E.1    Gorringe, K.L.2    Thompson, E.R.3    Opeskin, K.4    Boyle, S.E.5    Wang, Y.6
  • 19
    • 0141738581 scopus 로고    scopus 로고
    • Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas
    • Robanus-Maandag EC, Bosch CA, Kristel PM, Hart AA, Faneyte IF, Nederlof PM, et al. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. J Pathol 2003;201:75-82.
    • (2003) J Pathol , vol.201 , pp. 75-82
    • Robanus-Maandag, E.C.1    Bosch, C.A.2    Kristel, P.M.3    Hart, A.A.4    Faneyte, I.F.5    Nederlof, P.M.6
  • 22
    • 84864509652 scopus 로고    scopus 로고
    • FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
    • Jang MH, Kim EJ, Choi Y, Lee HE, Kim YJ, Kim JH, et al. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma. Breast Cancer Res 2012;14:R115.
    • (2012) Breast Cancer Res , vol.14
    • Jang, M.H.1    Kim, E.J.2    Choi, Y.3    Lee, H.E.4    Kim, Y.J.5    Kim, J.H.6
  • 23
    • 84859637667 scopus 로고    scopus 로고
    • Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
    • Hernandez L, Wilkerson PM, Lambros MB, Campion-Flora A, Rodrigues DN, Gauthier A, et al. Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J Pathol 2012;227:42-52.
    • (2012) J Pathol , vol.227 , pp. 42-52
    • Hernandez, L.1    Wilkerson, P.M.2    Lambros, M.B.3    Campion-Flora, A.4    Rodrigues, D.N.5    Gauthier, A.6
  • 24
    • 84868214754 scopus 로고    scopus 로고
    • Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression
    • Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, Ortiz-Melendez C, Lee WJ, Christensen R, et al. Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol 2012;181:1807-22.
    • (2012) Am J Pathol , vol.181 , pp. 1807-1822
    • Heselmeyer-Haddad, K.1    Berroa Garcia, L.Y.2    Bradley, A.3    Ortiz-Melendez, C.4    Lee, W.J.5    Christensen, R.6
  • 25
    • 81555216077 scopus 로고    scopus 로고
    • Gene expression profiling in breast cancer: Classification, prognostication, and prediction
    • Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 2011;378: 1812-23.
    • (2011) Lancet , vol.378 , pp. 1812-1823
    • Reis-Filho, J.S.1    Pusztai, L.2
  • 26
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • Cancer Genome Atlas Network
    • Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.
    • (2012) Nature , vol.490 , pp. 61-70
  • 28
    • 51049118140 scopus 로고    scopus 로고
    • An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
    • Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 2008;68:6084-91.
    • (2008) Cancer Res , vol.68 , pp. 6084-6091
    • Stemke-Hale, K.1    Gonzalez-Angulo, A.M.2    Lluch, A.3    Neve, R.M.4    Kuo, W.L.5    Davies, M.6
  • 29
    • 63849329936 scopus 로고    scopus 로고
    • Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
    • Marty B, Maire V, Gravier E, Rigaill G, Vincent-Salomon A, Kappler M, et al. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Res 2008;10:R101.
    • (2008) Breast Cancer Res , vol.10
    • Marty, B.1    Maire, V.2    Gravier, E.3    Rigaill, G.4    Vincent-Salomon, A.5    Kappler, M.6
  • 31
    • 78650675585 scopus 로고    scopus 로고
    • Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
    • Fedele CG, Ooms LM, Ho M, Vieusseux J, O'Toole SA, Millar EK, et al. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad SciUSA 2010;107:22231-6.
    • (2010) Proc Natl Acad SciUSA , vol.107 , pp. 22231-22236
    • Fedele, C.G.1    Ooms, L.M.2    Ho, M.3    Vieusseux, J.4    O'Toole, S.A.5    Millar, E.K.6
  • 32
    • 67651148274 scopus 로고    scopus 로고
    • Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling
    • Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, Bowtell D, et al. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 2009;16:115-25.
    • (2009) Cancer Cell , vol.16 , pp. 115-125
    • Gewinner, C.1    Wang, Z.C.2    Richardson, A.3    Teruya-Feldstein, J.4    Etemadmoghadam, D.5    Bowtell, D.6
  • 34
    • 73949156234 scopus 로고    scopus 로고
    • High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast
    • Troxell ML, Levine J, Beadling C, Warrick A, Dunlap J, Presnell A, et al. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol 2010;23:27-37.
    • (2010) Mod Pathol , vol.23 , pp. 27-37
    • Troxell, M.L.1    Levine, J.2    Beadling, C.3    Warrick, A.4    Dunlap, J.5    Presnell, A.6
  • 37
    • 80955181019 scopus 로고    scopus 로고
    • PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression
    • Kalinsky K, Heguy A, Bhanot UK, Patil S, Moynahan ME. PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression. Breast Cancer Res Treat 2011;129:635-43.
    • (2011) Breast Cancer Res Treat , vol.129 , pp. 635-643
    • Kalinsky, K.1    Heguy, A.2    Bhanot, U.K.3    Patil, S.4    Moynahan, M.E.5
  • 39
    • 0016704341 scopus 로고
    • The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4)
    • Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 1975;36:1-85.
    • (1975) Cancer , vol.36 , pp. 1-85
    • Fisher, E.R.1    Gregorio, R.M.2    Fisher, B.3    Redmond, C.4    Vellios, F.5    Sommers, S.C.6
  • 41
    • 84871238855 scopus 로고    scopus 로고
    • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    • Chandarlapaty S, Sakr RA, Giri D, Patil S, Heguy A, Morrow M, et al. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clin Cancer Res 2012;18:6784-91.
    • (2012) Clin Cancer Res , vol.18 , pp. 6784-6791
    • Chandarlapaty, S.1    Sakr, R.A.2    Giri, D.3    Patil, S.4    Heguy, A.5    Morrow, M.6
  • 42
    • 33847147313 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25: 118-45.
    • (2007) J Clin Oncol , vol.25 , pp. 118-145
    • Wolff, A.C.1    Hammond, M.E.2    Schwartz, J.N.3    Hagerty, K.L.4    Allred, D.C.5    Cote, R.J.6
  • 43
    • 77954526150 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    • Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010;28:2784-95.
    • (2010) J Clin Oncol , vol.28 , pp. 2784-2795
    • Hammond, M.E.1    Hayes, D.F.2    Dowsett, M.3    Allred, D.C.4    Hagerty, K.L.5    Badve, S.6
  • 47
    • 84863441069 scopus 로고    scopus 로고
    • Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions
    • Troxell ML, Brunner AL, Neff T, Warrick A, Beadling C, Montgomery K, et al. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod Pathol 2012;25:930-7.
    • (2012) Mod Pathol , vol.25 , pp. 930-937
    • Troxell, M.L.1    Brunner, A.L.2    Neff, T.3    Warrick, A.4    Beadling, C.5    Montgomery, K.6
  • 48
    • 78650922427 scopus 로고    scopus 로고
    • Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer
    • Pinhel IF, Macneill FA, Hills MJ, Salter J, Detre S, A'Hern R, et al. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res 2010;12:R76.
    • (2010) Breast Cancer Res , vol.12
    • Pinhel, I.F.1    Macneill, F.A.2    Hills, M.J.3    Salter, J.4    Detre, S.5    A'Hern, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.